These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 14613395)
1. Optimizing clinical and economic outcomes in asthma management: individualizing drug therapy to address the dual components of asthma. Navarro RP J Manag Care Pharm; 2002; 8(5 Suppl):2. PubMed ID: 14613395 [No Abstract] [Full Text] [Related]
3. Understanding the impact of asthma in the 21st century. Turk A J Manag Care Pharm; 2002; 8(5 Suppl):3-7. PubMed ID: 14613396 [TBL] [Abstract][Full Text] [Related]
4. Long-term management of asthma: how to improve outcomes. Self T; Nolan S Am J Manag Care; 1997 Sep; 3(9):1425-38; quiz 1441-2. PubMed ID: 10178488 [TBL] [Abstract][Full Text] [Related]
6. [Practical considerations in management of adult asthmatic patients]. Stey C Praxis (Bern 1994); 2000 Feb; 89(7):275-80. PubMed ID: 10705800 [TBL] [Abstract][Full Text] [Related]
7. Systematic analysis of outcomes evaluations applied to drug management programs. McAdam-Marx C; Schaaf DT; Holtorf AP; Eng B; Oderda GM Am J Manag Care; 2008 Nov; 14(11 Suppl):SP36-45. PubMed ID: 18991480 [TBL] [Abstract][Full Text] [Related]
8. IgE-blocking therapy for difficult-to-treat asthma: a brief review. Marshall GD; Sorkness CA Manag Care; 2004 Mar; 13(3):45-50. PubMed ID: 15074156 [TBL] [Abstract][Full Text] [Related]
9. Biomarker-driven care in asthma: are we there? Deykin A J Allergy Clin Immunol; 2006 Sep; 118(3):565-8. PubMed ID: 16950271 [TBL] [Abstract][Full Text] [Related]
10. Economic analysis of asthma practices. Stempel DA Am J Manag Care; 2000 Oct; 6(17 Suppl):S930-6; discussion S937-9. PubMed ID: 11184564 [TBL] [Abstract][Full Text] [Related]
12. Managing asthma: an evidence-based approach to optimizing inhaled corticosteroid treatment. Fromer L South Med J; 2010 Oct; 103(10):1038-44. PubMed ID: 20818314 [TBL] [Abstract][Full Text] [Related]
13. Community pharmacy-based pharmaceutical care for asthma patients. Mangiapane S; Schulz M; Mühlig S; Ihle P; Schubert I; Waldmann HC Ann Pharmacother; 2005 Nov; 39(11):1817-22. PubMed ID: 16219893 [TBL] [Abstract][Full Text] [Related]
14. The economic value of individualizing drug therapy. Navarro RP Manag Care Interface; 1997 Oct; 10(10):96-8. PubMed ID: 10174423 [No Abstract] [Full Text] [Related]
15. The relationship between asthma, asthma control and economic outcomes in the United States. Sullivan PW; Slejko JF; Ghushchyan VH; Sucher B; Globe DR; Lin SL; Globe G J Asthma; 2014 Sep; 51(7):769-78. PubMed ID: 24697738 [TBL] [Abstract][Full Text] [Related]
16. [Quality assurance of drug therapy for patients with asthma. Health economic analysis]. Søndergaard B; Thorleifsson S; Herborg H; Frøkjaer B; Hepler CD; Ersbøll BK Ugeskr Laeger; 2000 Jan; 162(4):480-6. PubMed ID: 10697444 [TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics and pancreatic cancer treatment. Optimizing current therapy and individualizing future therapy. Kang SP; Saif MW JOP; 2008 May; 9(3):251-66. PubMed ID: 18469437 [TBL] [Abstract][Full Text] [Related]
18. [Economic study of dialysis using the cost-per-procedure method according to clinical protocols]. Rodríguez-Carmona A; Castro A; Pérez Fontán M; Mojón M Nefrologia; 2007; 27(3):359-69. PubMed ID: 17725456 [TBL] [Abstract][Full Text] [Related]
19. Management of childhood and adolescent asthma. 1994 consensus. South African Childhood Asthma Working Group. S Afr Med J; 1994 Dec; 84(12):862-6. PubMed ID: 7570241 [TBL] [Abstract][Full Text] [Related]